Plasmablastic Lymphoma

14 clinical trials · Condition

Record	Firm	Date
Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients. (NCT04915248)	Fondazione Italiana Linfomi - ETS	2022-07-11
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma (NCT04139304)	AIDS Malignancy Consortium	2021-05-24
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas (NCT03038672)	National Cancer Institute (NCI)	2018-12-21
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant (NCT02797470)	AIDS Malignancy Consortium	2016-06-23
Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma (NCT02481310)	Northwestern University	2015-10-28
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas (NCT01193842)	National Cancer Institute (NCI)	2010-10-06
Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma (NCT01092182)	National Cancer Institute (NCI)	2010-03-25

Every clearance here is in the API, with alerts when new ones post.